Canadian Cancer Trials Group Bulletins


Recent Publication

There was one recent publication related to Canadian Cancer Trials Group AL.2 (INT0129) -- Phase III Randomized Study of All-Trans Retinoic Acid versus Cytosine Arabinoside and Daunorubicin as Inductive Therapy for Patients with Previously Untreated Acute Promyelocytic Leukemia.

Gregory J, Haesook K, Alonzo T, Gerbring R, Woods W, Weinstein H, Shepherd L, Schiffer C, Appelbaum F, Willman C, Wiernik P, Rowe J, Tallman M, Feusner J. Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129. Pediatric Blood & Cancer 53: 1005-10, 2009.